InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the full record of transactions filed by Firestone Karen. Officer active across 1 company, notably Amylyx Pharmaceuticals, Inc.. Aggregated, 5 filings have been logged. Split: 5 buys · 0 sell. Total volume traded: €311k. Activity tracked since 16 March 2023. The latest transaction was disclosed on 21 May 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Karen Firestone is a declarant and Director at Amylyx Pharmaceuticals, Inc. (XNAS). She has filed 5 forms in total, and, across the 5 sampled recent filings, all transactions are acquisitions, totaling EUR 310511 between 2023-03-20 and 2026-05-26, with no reported sales.